Index of reports
> Cases with Generalised Oedema (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) where reactions include generalised oedema. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cerubidine side effects in 5 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-16
Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Sepsis, Generalised Oedema
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Gleevec
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-01
Kidrolase
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Methotrexate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine Sulfate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Cerubidine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Aplasia, Stomatococcal Infection, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Spleen Disorder, Oral Disorder, Sepsis, Hypoxia, Acute Respiratory Distress Syndrome, Pleural Effusion, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 25 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cerubidine
Dosage: 31 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Dosage: 12 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine
Dosage: 1.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Kidrolase
Dosage: 4800 iu, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cyclophosphamide
Dosage: 780 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Generalised Oedema, Ascites, Pericardial Effusion, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Dosage: 780 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
Cytarabine
Dosage: 25 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Methotrexate
Dosage: 12 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine
Dosage: 1.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Kidrolase
Dosage: 4800 iu, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Possible Cerubidine side effects in 5 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-05
Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Sepsis, Generalised Oedema
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Gleevec
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cerubidine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Kidrolase
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cyclophosphamide
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-01
Vincristine Sulfate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-02
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Ascites, Pericardial Effusion, Generalised Oedema, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kidrolase
Dosage: 4800 iu, unk
Start date: 2011-10-06
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Dosage: 25 mg, unk
Start date: 2011-10-10
End date: 2011-10-14
Cyclophosphamide
Dosage: 780 mg, unk
Start date: 2011-10-06
Vincristine Sulfate
Dosage: 1.2 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-10-13
End date: 2011-10-21
Methotrexate
Dosage: 12 mg, unk
Start date: 2011-10-03
End date: 2011-10-14
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-31
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Oral Disorder, Sepsis, Pleural Effusion, Hypoxia, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 1.2 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Dosage: 25 mg, unk
Start date: 2011-10-10
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Dosage: 12 mg, unk
Start date: 2011-10-03
End date: 2011-10-14
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Dosage: 780 mg, unk
Start date: 2011-10-06
Kidrolase
Dosage: 4800 iu, unk
Start date: 2011-10-06
End date: 2011-10-14
|